Industry reports
Editor highlights

Pharmaceutical Analysis & Statistics in Netherlands, April 2014

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

1-26 of about 200 reports
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2013
  • by Business Monitor International

BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical market, which has attracted significant domestic and foreign investment over the years. Demographic ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Business Forecast Report Q4 2013

Netherlands Business Forecast Report Q4 2013

  • $ 1 208
  • Industry report
  • September 2013
  • by Business Monitor International

Core Views The Dutch economy will slide further into recession in the coming quarters, but will likely see a return to positive growth in 2014. With unemployment rising and the fiscal deficit widening, ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2013
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals ...

  • Industries : Drug and Medication
  • Countries : Netherlands
The Pharmaceutical Market: Netherlands, Business Monitor International

The Pharmaceutical Market: Netherlands, Business Monitor International

  • $ 1 337
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE NETHERLANDS While the Netherlands is a low-risk market from the point of view ...

  • Industries : Drug and Medication
  • Countries : Netherlands



ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.